Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. J Clin Invest. 2021 11 15; 131(22).